Cingulate (CING) Earnings Date, Estimates & Call Transcripts $4.49 -0.25 (-5.18%) As of 01:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cingulate Earnings Summary Cingulate issued Q1 2025 earnings on May 8, 2025, reporting an EPS of -$1.04, which missed the consensus estimate of -$1.00 by $0.04. With a trailing EPS of -$8.48, Cingulate's earnings are expected to grow next year, from ($11.69) to ($4.95) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 8) -$1.00 Actual EPS (May. 8) -$1.04 Missed By -$0.04 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)CING Upcoming EarningsCingulate's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled on Monday, August 11, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Cingulate Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cingulate and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCING Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Cingulate Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.05-$0.96-$1.01Q2 20252-$0.93-$0.87-$0.90Q3 20252-$0.75-$0.58-$0.67Q4 20252-$0.56-$0.40-$0.48 FY 2025 8 -$3.29 -$2.81 -$3.05 Q1 20261-$0.46-$0.46-$0.46Q2 20261$0.54$0.54$0.54Q3 20261-$0.63-$0.63-$0.63Q4 20261-$0.72-$0.72-$0.72 Cingulate Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/8/2025Q1 2025-$1.00-$1.04 -$0.04-$1.04--11/7/2024--$2.22-$1.83+$0.39-$1.83--8/13/2024--$5.64-$5.47+$0.17-$5.47--5/8/2024Q1 2024 -$2.20-$0.60+$1.60-$0.60--11/13/2023Q3 2023 -$4.80-$6.00 -$1.20-$6.00--8/14/2023Q2 2023 --$11.40--$0.57-- Cingulate Earnings - Frequently Asked Questions When is Cingulate's earnings date? Cingulate has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on CING's earnings history. Did Cingulate beat their earnings estimates last quarter? In the previous quarter, Cingulate (NASDAQ:CING) missed the analysts' consensus estimate of ($1.00) by $0.04 with a reported earnings per share (EPS) of ($1.04). Learn more on analysts' earnings estimate vs. CING's actual earnings. How much profit does Cingulate generate each year? Cingulate (NASDAQ:CING) has a recorded net income of -$15.55 million. CING has generated -$8.48 earnings per share over the last four quarters. What is Cingulate's EPS forecast for next year? Cingulate's earnings are expected to grow from ($11.69) per share to ($4.95) per share in the next year. More Earnings Resources from MarketBeat Related Companies Surrozen Earnings Results Immix Biopharma Earnings Results Acumen Pharmaceuticals Earnings Results Immunic Earnings Results VolitionRx Earnings Results Anebulo Pharmaceuticals Earnings Results Pyxis Oncology Earnings Results Adaptimmune Therapeutics Earnings Results PyroGenesis Canada Earnings Results Verrica Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft Earnings3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor Hopes This page (NASDAQ:CING) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
